Genomic analysis reveals cellular cause of type 1 diabetes
Posted: 20 May 2021 | Victoria Rees (Drug Target Review) | No comments yet
Combining two genomic methodologies, researchers have shown that pancreatic exocrine cells are implicated in type 1 diabetes.


By mapping its genetic underpinnings, researchers at University of California, San Diego, US, have identified a predictive causal role for specific cell types in type 1 diabetes.
According to the researchers, type 1 diabetes is characterised by the impairment and loss of insulin-producing pancreatic beta cells and subsequent hyperglycemia. The mechanisms of type 1 diabetes, including how autoimmunity is triggered, are poorly understood. Due to its strong genetic component, numerous genome-wide association studies (GWAS) have been conducted in recent years where researchers compare whole genomes of persons with the same disease or condition. In the case of type 1 diabetes, identified at-risk variants have largely been found in the non-coding regions of the genome.
In the new study, the team integrated GWAS data with epigenomic maps of cell types in peripheral blood and the pancreas. Epigenomic mapping details how and when genes are turned on and off in cells, thus determining the production of proteins vital to specific cellular functions.
Reduce preclinical failures with smarter off-target profiling
24 September 2025 | 15:00PM BST | FREE Webinar
Join this webinar to hear from Dr Emilie Desfosses as she shares insights into how in vitro and in silico methods can support more informed, human-relevant safety decisions -especially as ethical and regulatory changes continue to reshape preclinical research.
What you’ll learn:
- Approaches for prioritizing follow-up studies and refining risk mitigation strategies
- How to interpret hit profiles from binding and functional assays
- Strategies for identifying organ systems at risk based on target activity modulation
- How to use visualization tools to assess safety margins and compare compound profiles
Register Now – It’s Free!
Specifically, researchers performed the largest-to-date GWAS of type 1 diabetes, analysing 520,580 genome samples to identify 69 novel association signals. They then mapped 448,142 cis-regulatory elements (non-coding DNA sequences in or near a gene) in pancreas and peripheral blood cell types.
“By combining these two methodologies, we were able to identify cell type-specific functions of disease variants and discover a predictive causal role for pancreatic exocrine cells in type 1 diabetes, which we were able to validate experimentally,” said senior author Assistant Professor Kyle Gaulton.
The team say that pancreatic exocrine cells produce enzymes secreted into the small intestine, where they help digest food.
“The implication is that exocrine cell dysfunction might be a major contributor to disease. This study provides a genetic roadmap from which we can determine which exocrine genes may have a role in disease pathogenesis,” said co-author Professor Maike Sander.
The findings are published in Nature.
Related topics
Disease Research, Genetic Analysis, Genomics, Molecular Biology, Molecular Targets
Related conditions
Diabetes, type 1 diabetes
Related organisations
University of California San Diego
Related people
Assistant Professor Kyle Gaulton, Professor Maike Sander